ArticleEuropean journal of nuclear medicine and molecular imaging2018

How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience.

Olarn Roengvoraphoj et al.PubMed ↗Publisher ↗

No numbers read from the abstract.